Association of Medical Research Charities

Aisling Burnand, Chief Executive Officer of the Association of Medical Research Charities
Over 30 years ago, a small group of diverse medical research charities formed the Association of Medical Research Charities (AMRC) to unite the sector and provide it with a leading voice. Since then, their membership has grown to 146 charities and they continue to lead and support the sector in delivering high-quality research that saves and improves lives. The AMRC is now the UK’s national membership organisation for health and medical research charities. In this exclusive interview, we speak with Aisling Burnand, AMRC’s Chief Executive, to hear about their vital work.
As the Chief Executive of AMRC, what are your vision and aims for the future?
As CEO, my vision is a future where the voice of patients, who are experts by experience, is given equal parity in shaping research and innovation priorities in a world class UK research environment.
The AMRC will be able to ensure that research charities are better prepared for future challenges and provide them with more collaborative opportunities that will deliver benefits to patients sooner.
What specific roles are filled by medical research charities in the overall research landscape?
Charities play a crucial role in the UK’s medical research landscape, creating a much more diverse funding landscape than most other countries and ensuring that excellent research can be funded. Collectively our member charities spent £1.3 billion on medical and health research in the UK in 2018. This accounts for 41% of all publicly funded medical research nationally: more than the Medical Research Council or the National Institute of Health Research.
Charities Supply the UK’s Skills Pipeline
Medical research charities invest with a long-term vision in human capital and the development of skills. In 2018, AMRC member charities were funding 17,000 researchers which span all essential roles in the research process, including 1,700 PhD students in universities across the UK. Charities are committed to growing the skills pipeline to deliver future generations of researchers trained in new and emerging fields, who are equipped to work across disciplines in order to tackle complex research challenges.
Charities Spark Further Investment in UK R&D
Charities are often the only funders in early-stage, preliminary research – de-risking ambitious projects for future investors and paving the way for other funders such as industry. In the last decade, funding from medical research charities leveraged over £196 million in funding from UK and international companies.
Charities Fund from the Patient’s Perspective
Patients are at the heart of many medical research charities. The research that charities fund is often in response to patient need and aims to communicate and meet these needs. Thanks to this close relationship, many medical research charities are funding research that could result in truly transformative outcomes for patients.
Charities are Entrepreneurial and Innovative
Charities are increasingly seeking innovative and novel approaches to investing in research, in order to maximise the benefits for patients. They often act like entrepreneurs and seek collaborative partners to achieve transformative goals. In the last decade, researchers funded by AMRC charities created over 61 spin out companies; and contributed to the production of 550 medical products including drugs, medical devices and diagnostic tools.
Charities are Honest Brokers
Charities can bring together university researchers, funders, small and medium-sized enterprises, regulators, patients and others in areas of unmet need. Working together, they can more efficiently define problems, craft research proposals and identify funding sources to expedite solutions through cross-disciplinary, lateral and radical thinking.
How do you support member charities in promoting the delivery of high-quality health and medical research?
We equip our member charities with regular guidance and training, provide quality standards and carry out an audit every five years to ensure they are supporting the best, most impactful research and researchers. This in turn helps them to deliver the changes that really matter to patients.
With our member charities funding £13 billion in medical research over the last 10 years it’s been essential for us to help them maximise the impact of their investment. In order to do this, we play a vital role in influencing the research environment – from forging partnerships, to voicing our member charities’ concerns and ideas to policy makers, to developing position statements – we ensure medical research charities get the recognition and voice that they deserve and need.
Researchers are increasingly required to demonstrate the impact of their research. How do you feel we should best measure the impact of research?
Medical research charities are committed to funding research that positively impacts people living with health conditions or diseases. For many charities this is only made possible through public donations and so they must let the public know how their money is being spent and what impact it is having.
The pathway to impact is rarely linear. Instead, it often involves many different funders and research teams over a long period of time. This cumulative nature of impact makes it challenging to track in an effective way.
We’re helping a number of our member charities use an online tool called Researchfish that allows them to collect data on the outcomes of their research funding over time. Many of our charities also choose to gather outcomes from research through other methods.
The member charities that do collect data on research outcomes through Researchfish enable us to pool their data and perform an in-depth cross-sector analysis of their impact. We categorise their outcomes into five impact areas:
o Generating new knowledge
o Translating research ideas into new products and services
o Influencing policy and other stakeholders
o Stimulating new research via new funding or partnerships
o Developing the human capacity to do research
You can find out more in our sector impact report which is available online for anyone to read. By developing this impact report, we hope to demonstrate the many different ways that impact can be evidenced.
Why do you feel patients are so critical to the research process?
It’s vital that people with health conditions, and their carers, are given the opportunity to influence and participate in research. There is a building body of evidence of the positive impact that involving patients and the public can have. It ensures that the right research is done, and that the research is done right.
No matter how complicated the research, or how brilliant the researcher, patients are experts by experience and always offer unique invaluable insights. Their advice when designing, implementing, and evaluating research invariably makes studies more effective, more credible and often more cost effective as well.
The experience of living with a health condition or caring for a loved one can provide a vital and different perspective to researchers when shaping or evaluating new programmes of research.
What challenges do you see on the horizon for health and medical research charities in the United Kingdom? How might these challenges be best managed?
If there is one guaranteed thing in today’s world it is uncertainty, change, and unpredictability.
Disruption to EU research networks and funding streams as well as to the flow of skills and talent from the EU are already being felt as a result of the UK’s decision to leave the EU. The shape of the UK’s future relationship with the EU will impact many aspects of the UK research and innovation landscape and medical research charities may have to adapt to a new state of play.
According to the World Economic Forum we have already entered an intense period of unprecedented, exponential change. The rapid advances in, and fusion of, technology and biotechnology, the rise in algorithms and automation, and big increases in data collection, storage, and AI manipulation – all will combine and lead to a scale of transformation never before experienced. Charities need to get ahead of the curve.
The UK has an ageing population and people are increasingly living with a number of different conditions. In order to pursue research that can truly have a meaningful impact on patients, charities must react to the increasing incidence of multiple long-term conditions. This could require the traditional approach to health research to change, with collaboration taking on a new level of importance.
Data driven technologies are likely to become the mainstay of our future health care and research system. Data currency is likely to become significant. Charities, being closely connected with patient communities and highly trusted, have great responsibility to approach this space with transparency and openness, making sure that patient data is protected with rigorous ethical frameworks whilst the opportunities of new technologies are capitalised on.
We’ve developed a report which uncovers some of the excellent ways charities are taking the initiative and responding to the changing environment around them. This is intended to help our member charities reflect on their preparedness for challenges on the horizon.
Reference
https://doi.org/10.33548/SCIENTIA417
Creative Commons Licence
(CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More articles you may like
Prof Han Lamers – Prof Dr Bettina Reitz-Joosse | The Politics of Language: How Latin Helped Shape Mussolini’s Italy
When wandering through Italian cities today, visitors will encounter Latin inscriptions on all manner of buildings and monuments. While many date back to ancient Rome, the Middle Ages, or the Renaissance, others were created during Benito Mussolini’s Fascist regime (1922–1943). These Latin texts weren’t merely decorative — they were deliberately crafted political tools that helped forge connections between Fascist Italy and ancient Rome, embedding the regime’s ideology into the very fabric of Italian society.
Ongoing research by Professor Han Lamers (University of Oslo) and Professor Bettina Reitz-Joosse (University of Groningen) reveals how Fascist Italy weaponized ancient Rome’s language to legitimise its power and connect Mussolini’s regime to Italy’s imperial past. Their projects involve collaboration with an international team of mostly junior researchers based in Norway, the Netherlands, Austria, and Italy.
Gopal Ranganathan | The Use of Artificial Intelligence in Personalised Airline Services
In today’s competitive airline industry, providing personalised services to passengers is becoming increasingly important for customer satisfaction and business success. Gopal Ranganathan from Quad Optima Analytics has developed an innovative artificial intelligence system to help airline executives implement and govern personalisation programmes. This cutting-edge technology aims to increase profits by tailoring services to individual customers while maintaining sound revenue management principles.
Shirley C. Strum | Learning from baboons
Shirley C. Strum has spent over 50 years studying wild baboons in Kenya. During that time, she has pioneered new ideas about baboons, about society, about nature, about science and about evolution. As she recounts in her new book Echoes of Our Origins: baboons, humans and nature, she was the first to suggest that baboon society is not based on male aggression and dominance, but that both males and females have effective non-aggressive alternatives. These “social strategies of competition and defence” rely on social relationships that create a “social contract” based on social sophistication, social intelligence, and collaboration, even without the benefits of human characteristics like symbols, language and culture.
Dr JoLee Sasakamoose – Dr Mamata Pandey | Empowering Indigenous Health: The Indigenous Wellness Research Collaborative in Saskatchewan
The Indigenous Wellness Research Collaborative is a transformative alliance dedicated to advancing health systems and service delivery for Indigenous communities across Saskatchewan. Founded a decade ago and co-led by Dr Mamata Pandey, a research scientist at the Saskatchewan Health Authority, and Dr JoLee Sasakamoose (M’Chigeeng First Nation), Canadian Institute of Health Research Chair in Indigenous Wellness and Health Equity at the University of Regina, their team’s work is rooted in a commitment to Indigenous leadership and community-defined wellness goals. Guided by the Cultural Responsiveness Framework, the Collaborative prioritises creating ethical spaces that serve as a middle ground for respect, reciprocity, and authentic partnerships. The team employs a strengths-based approach to health research, centering Indigenous methodologies that respect the interconnectedness of spiritual, mental, emotional, and physical well-being.